International Clinical and Medical Case Reports Journal (ISSN: 2832-5788) | Volume 1, Issue 4 | Case Series | Open Access

Myositis Ossificans Tramatica: A Series of 15 Patients Presented at End Stage Disease and Review of the Literature

Hatim Yahya Uslu*

Department of General Surgery, Tobb Etu University, Turkey

*Correspondence to: Hatim Yahya Uslu 

Fulltext PDF


Background: Myositis Ossificans Traumatica (MOT) is self-limiting disorder characterized by bone and cartilage development in soft tissue after an injury. Its diagnosis is easier shortly after injury among professional sportsmen. But it becomes difficult in public particularly when present late to physicians. Although it is a self-limited disorder to shorten the period of healing, different non-surgical methods are applied. Sometimes the condition become so disturbing that surgical treatment becomes compulsory.

Cases presentation: Herein we repot a15 MOT patients who presented at disease end stage and treated surgically because they were beyond non-surgical treatment modality. It is a retrospective study in which all the patients’ characteristics, age, gender, lesions locations and their pathological result were discussed.

To our knowledge, few series of MOT reported in the literature. All of the patients in those studies were professional sport practitioner whose diagnosis and treatment could be started at the very early stages of the disease and so surgical treatment was not mandatory. In contrast, our series contain normal public whose diagnosis was late and treatment was surgical because of their late presentation.

Conclusion: Myositis traumatica is a self-limited disorder, it’s healing can be accelerated by non-surgical treatments models but when diagnosis made late, it can progress to the extent that needs surgical intervention


Trauma; Hematoma; Injury; Sarcoma


Hatim Yahya Uslu, Salih Müjdat Balkan, Omer Günhan, Bahtiyar Demiralp.Myositis Ossificans Tramatica: A Series of 15 Patients Presented at End Stage Disease and Review of the Literature.Int Clinc Med Case Rep Jour. 2022;1(4):1-9.